TOP
News Release
News Release
August 3, 2009
Taiho Pharmaceutical Co., Ltd.
Banyu Pharmaceutical Co., Ltd.
Taiho to Buy Tsukuba Research Institute from Banyu
TOKYO, August 3, 2009
TOKYO, August 3, 2009 -- Taiho Pharmaceutical Co., Ltd. and Banyu Pharmaceutical Co., Ltd. announced today that the two companies reached an agreement regarding the purchase of Banyu's Tsukuba Research Institute (TRI) by Taiho. Under the agreement, TRI's ownership will transfer to Taiho, from August 31, 2009.
Some of the TRI employees will join Taiho after the conclusion of this agreement. Taiho, which currently operates research facilities in Saitama and Tokushima Prefectures, will conduct research and development of oncology products also in Tsukuba.
As announced in October 2008, Banyu's basic research programs at TRI have been transferred to other sites as part of the global initiative to balance basic research capacity to support a sustainable pipeline flow. Banyu will continue to deliver innovative medicines and vaccines through clinical development programs conducted by its Clinical Development Institute in Tokyo.
About Tsukuba Research Institute
| Established | 1992 |
|---|---|
| Address | 3 ban-chi, Okubo, Tsukuba, Ibaraki-Prefecture |
| Land | 89,237 m2 |
| Buildings | Laboratories, machine room, transformer station, day dare center |
| Floor Space | 56,800 m2 |
MEDIA CONTACT
Taiho Pharmaceutical Public Relations Division
(Tokyo) +81-3-3293-2828
Banyu Pharmaceutical Communications Office
(Tokyo) +81-3-6272-1001
